Literature DB >> 18381869

Management of malignant pleural effusion associated with trapped lung syndrome.

Rizwan A Qureshi1, Sandra L Collinson, Roy J Powell, Peter O Froeschle, Richard G Berrisford.   

Abstract

Management of recurrent malignant pleural effusion associated with trapped lung syndrome remains problematic. An alternative treatment using a pleural catheter has been advocated. Between August 1999 and August 2002, 127 patients underwent thoracoscopy for malignant pleural effusion. Of these, 52 (41%) with trapped lung were managed by insertion of a pleural catheter. Mean age was 66 years (range, 42-89 years). The most frequent diagnosis was breast cancer. Spontaneous pleurodesis (drainage < 10 mL) occurred in 25 (48%) patients whose catheter was removed after 30 to 255 days (mean, 93.8 days). Symptomatic relief was achieved in 49 (94%) patients. Mean dyspnea score improved significantly from 3.0 to 1.9. Complications comprised catheter blockage, surgical emphysema, cellulitis, and loculated effusion in 2 patients each. Mean length of hospital stay was 3 days (range, 1-16 days). Median survival was 126 days (range, 10-175 days). We conclude that long-term placement of a pleural catheter provides effective palliation for malignant pleural effusion associated with trapped lung syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18381869     DOI: 10.1177/021849230801600208

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  7 in total

Review 1.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12

2.  Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion.

Authors:  Fernando Conrado Abrão; Igor Renato Louro Bruno de Abreu; Maria Gabriela Cavalcanti; José Franklin Soares Pompa-Filho
Journal:  J Bras Pneumol       Date:  2017-01-23       Impact factor: 2.624

Review 3.  Management of malignant pleural effusion: challenges and solutions.

Authors:  Erika Penz; Kristina N Watt; Christopher A Hergott; Najib M Rahman; Ioannis Psallidas
Journal:  Cancer Manag Res       Date:  2017-06-23       Impact factor: 3.989

Review 4.  Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration.

Authors:  Michal Mierzejewski; Piotr Korczynski; Rafal Krenke; Julius P Janssen
Journal:  Respir Res       Date:  2019-11-07

Review 5.  Malignant Pleural Effusion: Diagnosis and Management.

Authors:  Lucía Ferreiro; Juan Suárez-Antelo; José Manuel Álvarez-Dobaño; María E Toubes; Vanessa Riveiro; Luis Valdés
Journal:  Can Respir J       Date:  2020-09-23       Impact factor: 2.409

6.  Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.

Authors:  Deirdre B Fitzgerald; Calvin Sidhu; Charley Budgeon; Ai Ling Tan; Catherine A Read; Benjamin C H Kwan; Nicola Ann Smith; Edward T Fysh; Sanjeevan Muruganandan; Tajalli Saghaie; Ranjan Shrestha; Arash Badiei; Phan Nguyen; Andrew Burke; John Goddard; Morgan Windsor; Julie McDonald; Gavin Wright; Kasia Czarnecka; Parthipan Sivakumar; Kazuhiro Yasufuku; David J Feller-Kopman; Nick A Maskell; Kevin Murray; Y C Gary Lee
Journal:  Trials       Date:  2022-06-27       Impact factor: 2.728

7.  MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial.

Authors:  Claire Matthews; Carol Freeman; Linda D Sharples; Julia Fox-Rushby; Angela Tod; Nicholas A Maskell; John G Edwards; Aman S Coonar; Pasupathy Sivasothy; Victoria Hughes; Najib M Rahman; David A Waller; Robert Campbell Rintoul
Journal:  BMJ Open Respir Res       Date:  2019-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.